Patents by Inventor Mark J. Mescher
Mark J. Mescher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10913925Abstract: The systems and methods disclosed herein are generally related to a cell culture system. More particularly, the systems and methods enable the culturing and interconnecting of a plurality of tissue types in a biomimetic environment. By culturing organ specific tissue types within a biomimetic environment and interconnecting each of the organ systems in a physiologically meaningful way, experiments can be conducted on in vitro cells that substantially mimic the responses of in vivo cell populations. In some implementations, the system is used to monitor how organ systems respond to agents such as toxins or medications. The system enables the precise and controlled delivery of these agents, which, in some implementations, enables the biomimetic dosing of drugs in humans to be mimicked.Type: GrantFiled: November 23, 2016Date of Patent: February 9, 2021Assignees: The Charles Stark Draper Laboratory, Inc., The Massachusetts Institute of TechnologyInventors: Joseph Cuiffi, Jeffrey T. Borenstein, Anilkumar Harapanahalli Achyuta, Mark J. Mescher, Linda Griffith, Samuel Walker Inman
-
Patent number: 9764121Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir to supply drug into a delivery channel and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet of the delivery channel.Type: GrantFiled: November 3, 2014Date of Patent: September 19, 2017Assignees: THE CHARLES STARK DRAPER LABORATORY, INC., MASSACHUSETTS EYE AND EAR INFIRMARYInventors: Jason O. Fiering, Mark J. Mescher, Erin E. Pararas, Jeffrey T. Borenstein, William F. Sewell, Sharon G. Kujawa, Michael J. McKenna, Ernest S. Kim
-
Publication number: 20170137768Abstract: The systems and methods disclosed herein are generally related to a cell culture system. More particularly, the systems and methods enable the culturing and interconnecting of a plurality of tissue types in a biomimetic environment. By culturing organ specific tissue types within a biomimetic environment and interconnecting each of the organ systems in a physiologically meaningful way, experiments can be conducted on in vitro cells that substantially mimic the responses of in vivo cell populations. In some implementations, the system is used to monitor how organ systems respond to agents such as toxins or medications. The system enables the precise and controlled delivery of these agents, which, in some implementations, enables the biomimetic dosing of drugs in humans to be mimicked.Type: ApplicationFiled: November 23, 2016Publication date: May 18, 2017Inventors: Joseph Cuiffi, Jeffrey T. Borenstein, Anilkumar Harapanahalli Achyuta, Mark J. Mescher, Linda Griffith, Samuel Walker Inman
-
Patent number: 9651166Abstract: A microfluidic valve system includes a substrate, a valve seat a compliant membrane and a mechanically actuable displacement element. The substrate includes first and second channels embedded within it and includes a first layer of material and a second layer of material. The valve seat is in fluid communication with the first and second channels. Portions of the second layer of material form sidewalls of the second channel and the valve seat. The mechanically actuable displacement element applies a mechanical force to the compliant membrane to bring the compliant membrane into sealable contact with the valve seat, thereby closing the valve system.Type: GrantFiled: February 26, 2015Date of Patent: May 16, 2017Assignee: The Charles Stark Draper Laboratory, Inc.Inventors: Mark J. Mescher, Jason O. Fiering, Erin E. Swan
-
Patent number: 9528082Abstract: The systems and methods disclosed herein are generally related to a cell culture system. More particularly, the systems and methods enable the culturing and interconnecting of a plurality of tissue types in a biomimetic environment. By culturing organ specific tissue types within a biomimetic environment and interconnecting each of the organ systems in a physiologically meaningful way, experiments can be conducted on in vitro cells that substantially mimic the responses of in vivo cell populations. In some implementations, the system is used to monitor how organ systems respond to agents such as toxins or medications. The system enables the precise and controlled delivery of these agents, which, in some implementations, enables the biomimetic dosing of drugs in humans to be mimicked.Type: GrantFiled: July 25, 2013Date of Patent: December 27, 2016Assignees: The Charles Stark Draper Laboratory, Inc., The Massachusetts Institute of TechnologyInventors: Joseph Cuiffi, Jeffrey T. Borenstein, Anilkumar Harapanahalli Achyuta, Mark J. Mescher, Linda Griffith, Samuel Walker Inman
-
Patent number: 9293821Abstract: In various embodiments, an actuating mechanism is employed to displace a conductor disposed within a fluidic channel, thereby reconfiguring an electronic component.Type: GrantFiled: July 8, 2010Date of Patent: March 22, 2016Assignee: The Charles Stark Draper Laboratory, Inc.Inventors: Amy E. Duwel, Jason O. Fiering, Douglas W. White, Mark J. Mescher, Joseph M. Bauer, John R. Lachapelle, Bryan Mclaughlin, Frans Spaepen
-
Publication number: 20160003229Abstract: A variable, closed-loop apparatus for regulating a microfluidic flow that employs a low-power deflection assembly, which is surface-mounted over a flexible membrane overlying a chamber integrated into a microfabricated platform. A flexible membrane, movable between two positions, sealingly overlies the chamber. One of the positions of the membrane restricts the flow through the chamber to a greater degree than the other position. A deflection assembly disposed on the substrate over the membrane unidirectionally deflects the membrane, thereby regulating the flow through the chamber.Type: ApplicationFiled: July 9, 2015Publication date: January 7, 2016Inventors: Mark J. Mescher, Jason O. Fiering, Christopher E. Dube
-
Patent number: 9180054Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a body cavity of a patient over a period of time includes a variable-volume vessel defining a working chamber for receiving a drug and recirculating a therapeutic fluid. The fluid can contain a bodily fluid, such as, for example, perilymph, and a drug. The device allows for the controlled delivery of the therapeutic fluid to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear.Type: GrantFiled: January 6, 2011Date of Patent: November 10, 2015Assignees: The Charles Stark Draper Laboratory, Inc., Massachusetts Eye and Ear InfirmaryInventors: Jason O. Fiering, Mark J. Mescher, Sharon G. Kujawa, Michael J. McKenna, William F. Sewell
-
Publication number: 20150167863Abstract: A microfluidic device may include a substrate that defines a flow-control cavity and first and second channels in fluid communication with the flow-control cavity. A compliant membrane for regulating fluid flow through the flow-control cavity may surround at least a portion of the flow-control cavity.Type: ApplicationFiled: February 26, 2015Publication date: June 18, 2015Inventors: Mark J. Mescher, Jason O. Fiering, Erin E. Swan
-
Publication number: 20150157837Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir to supply drug into a delivery channel and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet of the delivery channel.Type: ApplicationFiled: November 3, 2014Publication date: June 11, 2015Inventors: Jason O. Fiering, Mark J. Mescher, Erin E. Pararas, Jeffrey T. Borenstein, William F. Sewell, Sharon G. Kujawa, Michael J. McKenna, Ernest S. Kim
-
Patent number: 9046192Abstract: A microfluidic device may include a substrate that defines a flow-control cavity and first and second channels in fluid communication with the flow-control cavity. A compliant membrane for regulating fluid flow through the flow-control cavity may surround at least a portion of the flow-control cavity.Type: GrantFiled: January 31, 2008Date of Patent: June 2, 2015Assignee: The Charles Stark Draper Laboratory, Inc.Inventors: Mark J. Mescher, Jason O. Fiering, Erin E. Swan
-
Patent number: 8999123Abstract: Electrodes are positioned substantially in contact with at least one surface of a solid to generate or absorb alkali metals when a voltage is applied between the electrodes.Type: GrantFiled: April 12, 2010Date of Patent: April 7, 2015Assignee: The Charles Stark Draper Laboratory, Inc.Inventors: Jonathan J. Bernstein, Mark J. Mescher, William L. Robbins
-
Patent number: 8876795Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir to supply drug into a delivery channel and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet of the delivery channel.Type: GrantFiled: February 2, 2012Date of Patent: November 4, 2014Assignees: The Charles Stark Draper Laboratory, Inc., Massachusetts Eye and Ear InfirmaryInventors: Jason O. Fiering, Mark J. Mescher, Erin E. Pararas, Jeffrey T. Borenstein, William F. Sewell, Sharon G. Kujawa, Michael J. McKenna, Ernest S. Kim
-
Publication number: 20140030752Abstract: The systems and methods disclosed herein are generally related to a cell culture system. More particularly, the systems and methods enable the culturing and interconnecting of a plurality of tissue types in a biomimetic environment. By culturing organ specific tissue types within a biomimetic environment and interconnecting each of the organ systems in a physiologically meaningful way, experiments can be conducted on in vitro cells that substantially mimic the responses of in vivo cell populations. In some implementations, the system is used to monitor how organ systems respond to agents such as toxins or medications. The system enables the precise and controlled delivery of these agents, which, in some implementations, enables the biomimetic dosing of drugs in humans to be mimicked.Type: ApplicationFiled: July 25, 2013Publication date: January 30, 2014Inventors: Joseph Cuiffi, Jeffrey T. Borenstein, Anilkumar Harapanahalli Achyuta, Mark J. Mescher, Linda Griffith, Samuel Walker Inman
-
Patent number: 8605374Abstract: A varifocal optical system includes a substantially circular membrane deposited on a substrate, and a ring-shaped PZT thin film deposited on the outer portion of the circular membrane. The membrane may be a MEMS-micromachined membrane, made of thermal oxide, polysilicon, ZrO2 and SiO2. The membrane is initially in a buckled state, and may function as a mirror or a lens. Application of an electric voltage between an inner and outer electrode on the piezoelectric thin film induces a lateral strain on the PZT thin film, thereby altering the curvature of the membrane, and thus its focal length. Focal length tuning speeds as high as 1 MHz have been demonstrated. Tuning ranges of several hundred microns have been attained. The varifocal optical system can be used in many applications that require rapid focal length tuning, such as optical switching, scanning confocal microscopy, and vibration compensation in optical storage disks.Type: GrantFiled: November 1, 2010Date of Patent: December 10, 2013Assignee: The Charles Stark Draper Laboratory, Inc.Inventor: Mark J. Mescher
-
Publication number: 20130053823Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir to supply drug into a delivery channel and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet of the delivery channel.Type: ApplicationFiled: February 2, 2012Publication date: February 28, 2013Inventors: Jason O. Fiering, Mark J. Mescher, Erin E. Pararas, Jeffrey T. Borenstein, William F. Sewell, Sharon G. Kujawa, Michael J. McKenna, Ernest S. Kim
-
Patent number: 8292083Abstract: A method and apparatus for continuously separating or concentrating particles that includes flowing two fluids in laminar flow through a magnetic field gradient which causes target particles to migrate to a waste fluid stream, and collecting each fluid stream after being flowed through the magnetic field gradient.Type: GrantFiled: April 18, 2008Date of Patent: October 23, 2012Assignees: The Charles Stark Draper Laboratory, Inc., Children's Medical Center CorporationInventors: Mathew Varghese, Jason O. Fiering, Donald E. Ingber, Nan Xia, Mark J. Mescher, Jeffrey T. Borenstein, Chong Wing Yung
-
Publication number: 20120007778Abstract: In various embodiments, an actuating mechanism is employed to displace a conductor disposed within a fluidic channel, thereby reconfiguring an electronic component.Type: ApplicationFiled: July 8, 2010Publication date: January 12, 2012Inventors: Amy E. Duwel, Jason O. Fiering, Douglas W. White, Mark J. Mescher, Joseph M. Bauer, John R. Lachapelle, Bryan McLaughlin, Frans Spaepen
-
Publication number: 20110295194Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a body cavity of a patient over a period of time includes a variable-volume vessel defining a working chamber for receiving a drug and recirculating a therapeutic fluid. The fluid can contain a bodily fluid, such as, for example, perilymph, and a drug. The device allows for the controlled delivery of the therapeutic fluid to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear.Type: ApplicationFiled: January 6, 2011Publication date: December 1, 2011Inventors: Jason O. Fiering, Mark J. Mescher, Sharon G. Kujawa, Michael J. McKenna, William F. Sewell
-
Publication number: 20110247942Abstract: Electrodes are positioned substantially in contact with at least one surface of a solid to generate or absorb alkali metals when a voltage is applied between the electrodes.Type: ApplicationFiled: April 12, 2010Publication date: October 13, 2011Inventors: Jonathan J. Bernstein, Mark J. Mescher, William L. Robbins